Angiotensin II receptor blockers (ARBs) are drugs generally well tolerated. Thereare few reports about cutaneous side effects of ARBs. The present authors describe herein fourcases of purpuric eruption mainly involving sites of friction in patients taking ARBs. These eruptionscompletely cleared after stopping the drug and implementing preservative measures to reducefriction.

Frictional purpuric eruption associated with angiotensin II receptor blockers

GUIDA, STEFANIA;
2014-01-01

Abstract

Angiotensin II receptor blockers (ARBs) are drugs generally well tolerated. Thereare few reports about cutaneous side effects of ARBs. The present authors describe herein fourcases of purpuric eruption mainly involving sites of friction in patients taking ARBs. These eruptionscompletely cleared after stopping the drug and implementing preservative measures to reducefriction.
2014
atenolol
hydrochlorothiazide
irbesartan
nickel sulfate
repaglinide
valsartan
zofenopril
angiotensin 1 receptor antagonist
antihypertensive agent
adult
aged
article
asymptomatic disease
case report
colon cancer
consultation
drug substitution
drug withdrawal
female
forearm
friction
hand palm
human
human tissue
hypertension
microbiological examination
middle aged
non insulin dependent diabetes mellitus
patient history of surgery
purpuric rash
skin allergy
skin biopsy
treatment duration
chemically induced
Drug Eruptions
Exanthema
male
very elderly
Aged
80 and over
Angiotensin II Type 1 Receptor Blockers
Antihypertensive Agents
Drug Eruptions
Drug Substitution
Exanthema
Female
Friction
Humans
Hypertension
Male
Middle Aged
angiotensin II receptor blockers
cutaneous side effects
purpuric dermatitis
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11768/134631
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 4
  • ???jsp.display-item.citation.isi??? 3
social impact